Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
CNS & Neurological Disorders Drug Targets|March 14, 2019
Clinical Characteristics and Possible Drug Targets in Autosomal Dominant Spinocerebellar AtaxiasLaszlo Szpisjak, Denes Zadori, Peter Klivenyi, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 25, 2009
Neuroprotective effects of probenecid in a transgenic animal model of Huntington's diseaseEniko Vamos, Krisztina Voros, Denes Zadori, et al.
Neuroscience Letters|May 10, 2017
Unlike PPARgamma, neither other PPARs nor PGC-1alpha is elevated in the cerebrospinal fluid of patients with multiple sclerosisLevente Szalardy, Denes Zadori, Krisztina Bencsik, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 21, 2020
Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathyBernadett Fakan, Zita Reisz, Denes Zadori, et al.
Current Topics in Medicinal Chemistry|October 4, 2012
Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunctionLevente Szalardy, Denes Zadori, Jozsef Toldi, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 11, 2020
Correction to: Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathyBernadett Fakan, Zita Reisz, Denes Zadori, et al.
Neuroscience Letters|September 12, 2013
Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosisLevente Szalardy, Denes Zadori, Ervin Tanczos, et al.
Behavioural Brain Research|July 19, 2016
Lack of age-related clinical progression in PGC-1α-deficient mice - implications for mitochondrial encephalopathiesLevente Szalardy, Mate Molnar, Rita Torok, et al.
Brain Research|February 6, 2017
Effect of MPTP on mRNA expression of PGC-1α in mouse brainRita Torok, Andras Salamon, Evelin Sumegi, et al.
Pageof 2